Valiant Laboratories Ltd
Ticker: VALIANTLAB
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
82.74
Market Cap
449.38
Debt/Equity
0.5193
ROE %
-0.942
PB
1.9179
Promoter %
74.939
Pledge %
0.000
1Y Rev Growth %
-27.605
5Y Rev Growth %
NP Margin %
-1.599
NP Margin 5Y Avg %
Trading Reference
1M Return %
-3.769
6M Return %
-8.044
1Y Return %
-20.840
% Away 52W High
46.149
% Away 52W Low
18.467
Daily Volume
13475
Investment Verdict
Buy
Score 77/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 19/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Valiant Laboratories Ltd is currently trading near a strong support level, with the 50-day EMA indicating a bullish trend. If it breaks above the resistance level, there is a high probability of upside movement. However, if it falls below the support, downside risks increase significantly.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
G
Genus Paper & Boards Ltd
Genus Paper & Boards Ltd presents a risky investment opportunity due to inconsistent growth and profitability metrics, alongside governance concerns.
View details
U
UVS Hospitality and Services Ltd
UVS Hospitality and Services Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
T
Tera Software Ltd
Tera Software Ltd presents a risky investment opportunity due to inconsistent growth and weak market sentiment.
View details
Q
Qualitek Labs Ltd
Qualitek Labs Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
G
Globe Civil Projects Ltd
Globe Civil Projects Ltd shows potential in a growing sector, but faces significant risks in execution and financial stability.
View details
L
Last Mile Enterprises Ltd
While Last Mile Enterprises Ltd has potential, there are several areas of concern that need to be addressed for a stronger investment case.
View details
S
Shankar Lal Rampal Dye-Chem Ltd
The company shows potential in a future-ready sector but faces significant challenges in growth, profitability, and valuation, making it a risky investment.
View details
B
Batliboi Ltd
Batliboi Ltd presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
View details
B
Brooks Laboratories Ltd
Brooks Laboratories Ltd shows potential in a growing sector, but faces challenges in growth consistency and profitability metrics.
View details
G
Grand Continent Hotels Ltd
While Grand Continent Hotels Ltd shows potential in a recovering sector, inconsistencies in growth and profitability metrics warrant caution.
View details
L
Ludlow Jute & Specialities Ltd
Ludlow Jute & Specialities Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
F
Freshara Agro Exports Ltd
Freshara Agro Exports Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
F
Filatex Fashions Ltd
Filatex Fashions Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns.
View details
M
Medicamen Biotech Ltd
Medicamen Biotech Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
View details
P
Pavna Industries Ltd
Pavna Industries Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
M
Moneyboxx Finance Ltd
Moneyboxx Finance Ltd shows potential for growth but faces several challenges that could impact its performance.
View details
Business Overview
Valiant Laboratories Ltd is a leading Indian pharmaceutical company dedicated to enhancing healthcare through innovative products. Catering to a diverse clientele, including healthcare providers and consumers, Valiant focuses on delivering quality medicines and healthcare solutions. The company's commitment to research and development ensures it stays ahead in the competitive market, making a significant impact on public health. With a strong emphasis on quality, affordability, and accessibility, Valiant Laboratories is a trusted partner in the healthcare journey.
- Established leader in the Indian pharmaceutical sector
- Focus on innovative healthcare solutions
- Commitment to quality and affordability
- Strong R&D capabilities
- Wide range of products for diverse health needs
Investment Thesis
Valiant Laboratories Ltd stands out as a strong investment choice due to its credible promoter group, robust growth potential in digital services, and attractive valuation compared to peers. This combination positions the company for sustained growth and shareholder value creation.
- Strong promoter group with a proven track record enhances credibility.
- Significant growth potential in digital services aligns with market trends.
- Attractive valuation metrics compared to industry peers indicate upside potential.
- Focus on innovation and quality positions Valiant for long-term success.
- Strong financial performance and strategic initiatives support growth outlook.
Opportunity vs Risk
Opportunities
- Strong demand for healthcare products
- Expanding into new markets
- Innovative product pipeline
- Strategic partnerships with distributors
Risks ⚠️
- Regulatory changes affecting operations
- Intense competition in the sector
- Supply chain disruptions
- Dependency on key suppliers
Peer Perspective
Valiant Laboratories Ltd trades at a discount compared to peers like Sun Pharmaceutical and Cipla, primarily due to lower growth rates. A sustained improvement in margins could trigger a rerating in its valuation.
Future Outlook
Valiant Laboratories Ltd is poised for growth, driven by innovative product pipelines and expanding market reach. Continued focus on execution and cost control will be crucial to fully realize its potential in the coming quarters.
AI FAQs for Retail Users
- Q: What does Valiant Laboratories Ltd do?A: Valiant Laboratories Ltd specializes in manufacturing and distributing pharmaceutical products and active pharmaceutical ingredients.
- Q: Is Valiant Laboratories Ltd a good investment?A: Investing depends on individual financial goals; consider researching the company and market conditions.
- Q: What are the risks of investing in Valiant Laboratories Ltd?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical sector.
- Q: How can I buy shares of Valiant Laboratories Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What is the dividend policy of Valiant Laboratories Ltd?A: Check the company's announcements for current dividend policies, as they may vary over time.
📊 Stock Investment Checklist (100 Points)
Valiant Laboratories Ltd • Updated: 2025-09-18 07:50:16
-
10BusinessHighThe sector shows potential but lacks a strong moat.
-
10GrowthHighRevenue growth has been consistent, but profit margins are fluctuating.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is inconsistent.
-
8ValuationHighValuation metrics are slightly above peers.
-
6BalanceGoodModerate debt levels with reasonable liquidity.
-
7GovernanceHighPromoter holding is good, but some pledging exists.
-
5DriversGoodLimited growth drivers identified; execution risks present.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Valiant Laboratories Ltd shows potential but faces challenges in profitability and growth drivers.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100